Mitochondrial Medicine 2018 Hinxton UK: Difference between revisions
From Bioblast
Laner Verena (talk | contribs) No edit summary |
No edit summary |
||
Line 7: | Line 7: | ||
|year=2018-05-09 | |year=2018-05-09 | ||
|journal=MitoGlobal | |journal=MitoGlobal | ||
|abstract= | |abstract=Mitochondrial Medicine conference, Hinxton, United Kingdom, 2018 | ||
}} | }} | ||
Line 17: | Line 16: | ||
:::: This conference will bring together leaders in the field of translational mitochondrial medicine, with a programme designed to engage and inspire the next generation of mitochondrial researchers. The meeting attracts international participants interested in mitochondrial diseases, working in molecular genetics, biochemistry, pathology, and clinical medicine | :::: This conference will bring together leaders in the field of translational mitochondrial medicine, with a programme designed to engage and inspire the next generation of mitochondrial researchers. The meeting attracts international participants interested in mitochondrial diseases, working in molecular genetics, biochemistry, pathology, and clinical medicine | ||
== Venue == Β | == Venue == Β | ||
Line 24: | Line 22: | ||
:::: CB10 1SA, UK | :::: CB10 1SA, UK | ||
::::[https://www.wellcomegenomecampus.org/ Location] | ::::[https://www.wellcomegenomecampus.org/ Location] | ||
== Programme == | == Programme == | ||
:::: Topics will include: Β | :::: Topics will include: Β | ||
::::* Precision diagnostics and new clinical biomarkers | :::::* Precision diagnostics and new clinical biomarkers | ||
::::* What determines the phenotype of mitochondrial diseases?Β Β | :::::* What determines the phenotype of mitochondrial diseases?Β Β | ||
::::* Autophagy-mitophagy: is it important for mitochondrial disease? | :::::* Autophagy-mitophagy: is it important for mitochondrial disease? | ||
::::* Fission/fusion defects in mitochondrial disease: cause or effect? | :::::* Fission/fusion defects in mitochondrial disease: cause or effect? | ||
::::* Mitochondrial biogenesis: the key to therapy? | :::::* Mitochondrial biogenesis: the key to therapy? | ||
::::* Gene editing to treat mitochondrial diseases | :::::* Gene editing to treat mitochondrial diseases | ||
::::* Clinical trials Β | :::::* Clinical trials Β | ||
::::* Late breaking clinical intervention studies | :::::* Late breaking clinical intervention studies | ||
::::* Translating microbiome science to impact global populations | :::::* Translating microbiome science to impact global populations | ||
::::A draft programme is available [https://coursesandconferences.wellcomegenomecampus.org/events/item.aspx?e=701 here]. | ::::A draft programme is available [https://coursesandconferences.wellcomegenomecampus.org/events/item.aspx?e=701 here]. | ||
== Organizers == | |||
:::: Scientific programme committee: | |||
:::::* '''Patrick Chinnery''' University of Cambridge, UK | |||
:::::* '''Marni Falk''' The Childrenβs Hospital of Philadelphia, USA | |||
:::::* '''Vamsi Mootha''' Harvard Medical School, USA | |||
:::::* '''Jan Smeitink''' Radboud UMC, The Netherlands | |||
:::::* '''Anu Suomalainen''' University of Helsinki, Finland | |||
:::::* '''Massimo Zeviani''' MRC Mitochondrial Biology Unit, Cambridge, UK | |||
:::: Conference organiser | |||
:::::* '''Lucy Criddle''' Wellcome Genome Campus, UK | |||
== Registration == | == Registration == | ||
Line 56: | Line 53: | ||
Β Β | Β Β | ||
== Lecturers and tutors == | == Lecturers and tutors == | ||
:::: The list | :::: The list can be found [https://coursesandconferences.wellcomegenomecampus.org/events/item.aspx?e=701 here] | ||
Β | |||
Β | |||
{{Labeling | {{Labeling |
Revision as of 12:41, 30 November 2017
MitoGlobal first |
Mitochondrial Medicine 2018 Hinxton UK
Hinxton, Cambridge UK, 2018 May 09-11. Mitochondrial Medicine conference |
Β» Conference
Wellcome Genome Campus (2018-05-09) MitoGlobal
Abstract: Mitochondrial Medicine conference, Hinxton, United Kingdom, 2018
General information
- The yearβs meeting aims to bridge the gap between our current understanding of the mechanisms and processes that go awry in mitochondrial disease and the novel approaches being developed to treat them. We will also include sessions on clinical trial design and cohorts that are trial ready. In addition, there will be a late-breaking session focusing on new clinical intervention studies.
- This conference will bring together leaders in the field of translational mitochondrial medicine, with a programme designed to engage and inspire the next generation of mitochondrial researchers. The meeting attracts international participants interested in mitochondrial diseases, working in molecular genetics, biochemistry, pathology, and clinical medicine
Venue
- Wellcome Genome Campus Conference Centre
- Hinxton, Cambridge
- CB10 1SA, UK
- Location
Programme
- Topics will include:
- Precision diagnostics and new clinical biomarkers
- What determines the phenotype of mitochondrial diseases?
- Autophagy-mitophagy: is it important for mitochondrial disease?
- Fission/fusion defects in mitochondrial disease: cause or effect?
- Mitochondrial biogenesis: the key to therapy?
- Gene editing to treat mitochondrial diseases
- Clinical trials
- Late breaking clinical intervention studies
- Translating microbiome science to impact global populations
- Topics will include:
- A draft programme is available here.
Organizers
- Scientific programme committee:
- Patrick Chinnery University of Cambridge, UK
- Marni Falk The Childrenβs Hospital of Philadelphia, USA
- Vamsi Mootha Harvard Medical School, USA
- Jan Smeitink Radboud UMC, The Netherlands
- Anu Suomalainen University of Helsinki, Finland
- Massimo Zeviani MRC Mitochondrial Biology Unit, Cambridge, UK
- Scientific programme committee:
- Conference organiser
- Lucy Criddle Wellcome Genome Campus, UK
- Conference organiser
Registration
Lecturers and tutors
- The list can be found here
Labels:
ORO, 2018, MitoGlobal
Listed under MitoGlobal Events